Study of Over-the-Counter Continuous Glucose Monitoring for Type 2 Diabetes
This study is looking at whether using periodic, over-the-counter continuous glucose monitoring (CGM) can help people with type 2 diabetes who don't use insulin better manage their blood sugar. CGM is a device that tracks your glucose levels throughout the day. The main goal is to see if using CGM every 30 or 90 days for six months can lower your A1C (a measure of average blood sugar over time) compared to your usual care. It also aims to see if CGM increases the time your blood sugar stays within a healthy range. We are enrolling 188 participants aged 18 and older who have type 2 diabetes and haven't used CGM in the past year. The study status is currently unclear.
- Study design
- This is an interventional study with a planned enrollment of 188 participants. It compares periodic use of continuous glucose monitoring to usual care.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your A1C will be measured at the beginning of the study and again at 6 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
T2D Intermittent Nonprescription Sensors for Informed Glucose Health Tracking
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Tamara Oser, MD · PRINCIPAL_INVESTIGATOR · University of Colorado Denver Anschutz Medical Campus
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Change in A1C from baseline to 6 monthsFrom enrollment to completion of study visits at 6 months
Change in A1C from baseline (enrollment) to 6 months.